Andon Health Co., Ltd. (SHE:002432)
China
· Delayed Price · Currency is CNY 39.70
+1.32 (3.44%)
May 16, 2025, 2:45 PM CST
Andon Health Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 2,323 | 2,578 | 3,172 | 26,265 | 2,340 | 1,996 | Upgrade
|
| Other Revenue | 13.85 | 13.85 | 58.66 | 50.51 | 57.06 | 11.9 | Upgrade
|
| Revenue | 2,337 | 2,592 | 3,231 | 26,315 | 2,397 | 2,008 | Upgrade
|
| Revenue Growth (YoY) | -6.45% | -19.77% | -87.72% | 997.80% | 19.36% | 184.36% | Upgrade
|
| Cost of Revenue | 718.25 | 784.96 | 1,275 | 5,529 | 884.82 | 906.6 | Upgrade
|
| Gross Profit | 1,619 | 1,807 | 1,956 | 20,786 | 1,512 | 1,102 | Upgrade
|
| Selling, General & Admin | 903.28 | 863.38 | 886.05 | 2,004 | 496.55 | 592.82 | Upgrade
|
| Research & Development | 295.05 | 260.69 | 278.46 | 264.89 | 66.73 | 76.54 | Upgrade
|
| Other Operating Expenses | 4.59 | 3.4 | 41.6 | 4.15 | 6.25 | 7.34 | Upgrade
|
| Operating Expenses | 1,208 | 1,130 | 1,203 | 2,286 | 592.96 | 686.29 | Upgrade
|
| Operating Income | 410.89 | 677.15 | 752.66 | 18,500 | 919.31 | 415.47 | Upgrade
|
| Interest Expense | -75.01 | -67.16 | -12.43 | -4.75 | -13.3 | -6.95 | Upgrade
|
| Interest & Investment Income | 829.38 | 800.45 | 735.36 | 274.1 | 62.35 | 327.17 | Upgrade
|
| Currency Exchange Gain (Loss) | -11.92 | -11.92 | 40.13 | 35.26 | -2.2 | -18.8 | Upgrade
|
| Other Non Operating Income (Expenses) | 26.95 | -2.26 | -2.8 | -1.98 | -3.86 | -2.65 | Upgrade
|
| EBT Excluding Unusual Items | 1,180 | 1,396 | 1,513 | 18,803 | 962.29 | 714.23 | Upgrade
|
| Impairment of Goodwill | - | - | -89.5 | -125.26 | - | -123.43 | Upgrade
|
| Gain (Loss) on Sale of Investments | 905.25 | 735.6 | 309.29 | -326.4 | 30.49 | -336.92 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.57 | 0.67 | -0.5 | -6.43 | 0.01 | -0.03 | Upgrade
|
| Asset Writedown | -24.65 | -25.45 | -153.14 | -46.95 | -1.88 | -24.29 | Upgrade
|
| Other Unusual Items | -0.11 | -0.2 | 1.28 | -39.85 | 8.72 | 10.19 | Upgrade
|
| Pretax Income | 2,061 | 2,107 | 1,580 | 18,258 | 999.63 | 239.75 | Upgrade
|
| Income Tax Expense | 293.96 | 306.83 | 231.11 | 1,774 | 65.23 | 2.92 | Upgrade
|
| Earnings From Continuing Operations | 1,767 | 1,800 | 1,349 | 16,484 | 934.4 | 236.83 | Upgrade
|
| Minority Interest in Earnings | -79.8 | -131.31 | -97.62 | -453.93 | -25.76 | 5.5 | Upgrade
|
| Net Income | 1,688 | 1,669 | 1,252 | 16,030 | 908.64 | 242.33 | Upgrade
|
| Net Income to Common | 1,688 | 1,669 | 1,252 | 16,030 | 908.64 | 242.33 | Upgrade
|
| Net Income Growth | 88.02% | 33.33% | -92.19% | 1664.19% | 274.96% | 264.68% | Upgrade
|
| Shares Outstanding (Basic) | 437 | 438 | 445 | 456 | 455 | 433 | Upgrade
|
| Shares Outstanding (Diluted) | 439 | 441 | 452 | 467 | 455 | 433 | Upgrade
|
| Shares Change (YoY) | -1.23% | -2.49% | -3.23% | 2.82% | 5.02% | -2.30% | Upgrade
|
| EPS (Basic) | 3.86 | 3.81 | 2.81 | 35.14 | 2.00 | 0.56 | Upgrade
|
| EPS (Diluted) | 3.84 | 3.78 | 2.77 | 34.30 | 2.00 | 0.56 | Upgrade
|
| EPS Growth | 90.36% | 36.73% | -91.93% | 1615.80% | 257.03% | 273.27% | Upgrade
|
| Free Cash Flow | 709.24 | 912.83 | 1,557 | 18,010 | 222.67 | 407.85 | Upgrade
|
| Free Cash Flow Per Share | 1.61 | 2.07 | 3.44 | 38.53 | 0.49 | 0.94 | Upgrade
|
| Dividend Per Share | 0.200 | 0.200 | 0.300 | 2.500 | 0.700 | 0.060 | Upgrade
|
| Dividend Growth | -33.33% | -33.33% | -88.00% | 257.14% | 1066.67% | - | Upgrade
|
| Gross Margin | 69.27% | 69.72% | 60.54% | 78.99% | 63.09% | 54.86% | Upgrade
|
| Operating Margin | 17.58% | 26.12% | 23.29% | 70.30% | 38.35% | 20.69% | Upgrade
|
| Profit Margin | 72.21% | 64.38% | 38.74% | 60.92% | 37.91% | 12.07% | Upgrade
|
| Free Cash Flow Margin | 30.35% | 35.22% | 48.20% | 68.44% | 9.29% | 20.31% | Upgrade
|
| EBITDA | 432.16 | 709.44 | 829.08 | 18,574 | 985.28 | 478.25 | Upgrade
|
| EBITDA Margin | 18.49% | 27.37% | 25.66% | 70.58% | 41.10% | 23.81% | Upgrade
|
| D&A For EBITDA | 21.27 | 32.3 | 76.42 | 74.18 | 65.97 | 62.78 | Upgrade
|
| EBIT | 410.89 | 677.15 | 752.66 | 18,500 | 919.31 | 415.47 | Upgrade
|
| EBIT Margin | 17.58% | 26.12% | 23.29% | 70.30% | 38.35% | 20.69% | Upgrade
|
| Effective Tax Rate | 14.26% | 14.56% | 14.62% | 9.71% | 6.53% | 1.22% | Upgrade
|
| Revenue as Reported | 2,337 | 2,592 | 3,231 | 26,315 | 2,397 | 2,008 | Upgrade
|
| Advertising Expenses | - | 108.82 | 82.77 | 70.38 | 51.22 | 84.16 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.